Promethera Biosciences
PrivateLast Round
Corporate Funding
Jun 30, 2021
Total Funding Raised
$134.6M
Company Overview
Promethera Biosciences is a biotechnology company that develops innovative cell-based therapies for the treatment of severe liver diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Promethera Biosciences Comparables
Compare Promethera Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GoLiver Therapeutics | 85% | |
| Morphocell Technologies | 82% | |
| HepaTx Corporation | 78% | |
Promethera Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jun 30, 2021 | ||||
| Series D | May 7, 2019 | ||||
| Series C Extension | Oct 28, 2016 | ||||
| Series C | Nov 25, 2014 | ||||
| Series B | Mar 28, 2012 | ||||
Series A | Nov 9, 2009 |
Promethera Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series C |
| Sopartec | Series A, Corporate Funding, Series B |
| SMS Investments | Series C, Series C Extension |
| LRM | Series A |
| Korea Investment Partners | Series D |
| Mitsui Global Investment | Series D, Series C, Series B |
| Shinsei Capital Partners | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2021
$24M raised from Fund+, Nivelinvest, Sambrinvest, and Sopartec.
- May 7, 2019
$53M round led by Innovation Fund and Itochu Corporation.
Promethera Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Promethera Biosciences's valuation, stock price, and market status.